The Medicare GLP-1 Bridge Program

If you or someone you love is on Medicare and has struggled to access GLP-1 medications because of cost, I have good news. Starting July 1, 2026, a new program called the Medicare GLP-1 Bridge Program will open the door for many Medicare beneficiaries to get these medications for a fraction of the usual price.

As a board-certified family medicine and obesity medicine physician, I've been following this program closely, and I want to break down exactly who qualifies, what it costs, and what you need to know about using GLP-1 medications safely if you're 65 or older.

What Is the Medicare Bridge Program?

The Bridge Program is currently scheduled to run from July 1, 2026 through December 31, 2027 — about 18 months. If early results show strong health outcomes, there's a real possibility the program gets extended. There's also a broader hope tied to this rollout: when Medicare leads the way on covering a treatment, commercial insurers often follow. So this program could be an important first step toward wider GLP-1 coverage for everyone, not just those on Medicare.

Under the Bridge Program, the expected copay for GLP-1 medication is $50 a month. Compare that to the typical out-of-pocket cost for brand-name GLP-1 medications, which usually runs $250 to $450 a month, and you can see why this is a meaningful shift for a lot of patients.

It's worth noting: the eligibility criteria for this program are not the same as the FDA-approved indications for GLP-1 medications. Insurance plans, including this one, are allowed to set their own qualifying rules, which is part of why this can feel confusing. Here's how it breaks down.

Who Qualifies: BMI and Health Condition Cutoffs

There are several paths to qualifying, based on a combination of BMI and certain health conditions. You only need to meet one pathway.

BMI of 35 or greater — qualifies on its own.
No additional condition is required at this level.

BMI of 30 or greater, plus one of the following:

• Heart failure
• Hypertension that remains uncontrolled (blood pressure of 140/90 or higher) despite being on at least two blood pressure medications
• Chronic kidney disease, stage 3A or higher (an eGFR of 59 or below on a recent metabolic panel)

BMI of 27 or greater, plus one of the following:

• Prediabetes (an A1C of 5.7–6.4%, or a fasting glucose of 100–125 mg/dL)
• A history of heart attack or stroke
• Peripheral arterial disease (PAD) with symptoms, such as leg pain or fatigue with walking, cramping, reduced hair growth on the legs, or skin color changes in the lower extremities

A few important notes on how these are applied:

• Use your highest-ever BMI, not your current one. This works the same way we treat other chronic conditions. If your blood pressure was once high enough to meet criteria for hypertension, you carry that diagnosis even once it's controlled with medication. The same logic applies here — if your BMI has ever been 35 or higher (or met one of the other thresholds), that history counts. Make sure this is documented in your chart or ask your doctor to note it.
• Many people don't know they already qualify. Conditions like prediabetes and early-stage chronic kidney disease are extremely common and frequently undiagnosed. Roughly one in three American adults has prediabetes, and many have never been told or were told not to worry about it. It's worth pulling your recent labs or asking your doctor directly whether you have a qualifying diagnosis already on file.
• PAD often goes unrecognized, too, and is sometimes mistaken for normal aging. If you've noticed new leg pain or fatigue with walking, cramping, or changes in your skin or leg hair, it's worth bringing up with your doctor.

Using GLP-1 Medications Safely After Age 65

Most Medicare beneficiaries are 65 or older, and this is a population that has historically been underrepresented in GLP-1 clinical research. That makes thoughtful, individualized care especially important. Here's what I emphasize with my older patients:

Go slow with dose titration. Increasing the dose too quickly raises the risk of side effects severe enough to cause dehydration, which can worsen kidney function and contribute to dizziness or falls. A slow, deliberate titration schedule matters more in this age group, not less.

Prioritize hydration and nutrition. Adequate fluid intake, regular meals, sufficient protein, and a well-rounded intake of carbohydrates, healthy fats, and micronutrients all help protect against the most common side effects. A multivitamin and the support of a registered dietitian can make a real difference here.

Protect muscle and strength. Especially for anyone new to exercise, working with a physical therapist or trainer to safely build strength, balance, and mobility is valuable — both for general health and to help preserve lean body mass while losing weight.

Reassess other medications as you lose weight. Once you've lost roughly 5% of your body weight, and especially by the 10–20% range, it's common to see meaningful improvement in blood pressure, blood sugar, and other markers. That often means your other medications — for blood pressure, diabetes, or other chronic conditions — will need to be adjusted or reduced. Regular follow-up with your doctor during this process is essential.

Don't skip bone health screening. GLP-1 use has been associated with changes in bone density, and osteoporosis is both common and frequently silent — it has no symptoms until a fracture occurs. Current guidelines recommend bone density screening for all women by age 65, with earlier screening appropriate for some. Recommendations for men vary by organization, but it's a conversation worth having with your doctor, particularly if you're starting or already using a GLP-1 medication.

The Bottom Line

The Medicare GLP-1 Bridge Program is an exciting step toward making effective metabolic treatment accessible to more people — but it has its own eligibility rules, separate from FDA-approved indications, so not everyone will qualify automatically. If you're on Medicare, it's worth checking your BMI history and existing diagnoses (prediabetes, chronic kidney disease, hypertension, PAD, or a history of heart attack or stroke) to see which pathway might apply to you.

If you're 65 or older and considering a GLP-1 medication, working with a physician experienced in obesity medicine — ideally supported by a dietitian and physical therapist — gives you the best chance of a safe, effective, and sustainable outcome.

At Missouri Metabolic Health, we specialize in exactly this kind of care: helping adults with obesity, prediabetes, metabolic syndrome, type 2 diabetes, and PCOS navigate safe and effective treatment, including GLP-1 medications, with a whole-person approach to lifestyle, nutrition, and long-term metabolic health. If you think you may qualify for the Bridge Program — or just want to understand your options — we'd love to help you figure out your next step.